The partner for healthcare companies
Lawyers in a different way: expert, creative, committed, concrete!
0
+
healthcare companies
0
+
groups of healthcare players
0
+
readers of our news
0
+
trainings and interventions per year
Your last news
What can we learn from the 2025 expenses and income report?
Article L. 111-11 of the French Social Security Code stipulates that the Union nationale des caisses d'assurance maladie (French National Union…
- Published on 25/07/2024
Requesting a price that is “too high” may justify the refusal of reimbursement… without negotiation!
The French Social Security Code allows ministers to refuse the reimbursement of a healthcare product if it is likely to…
- Published on 03/05/2024
Pharma package: pharmaceutical companies soon to be required to apply for medicinal product reimbursement?
The European Parliament has just adopted in first reading the "pharmaceutical package" which includes a new directive and a new…
- Published on 11/04/2024
Product paybacks: pricing agreements must be strictly interpreted (annulment of a CEPS decision)
The French Economic Committee for Health Products (CEPS) can negotiate or set paybacks on products reimbursed by the French health…
- Published on 09/04/2024
CEPS report: what the 2022 report says about delays and disputes
On January 23, 2024, the French Economic Committee for Health Products (“CEPS”) published its activity report for 2022. It describes…
- Published on 24/01/2024
Price/volume paybacks and reimbursable indications: a review of the judge’s recent rulings
As a reminder, with the aim of regulating health insurance expenditures, paybacks may be negotiated between the French Economic Committee…
- Published on 16/01/2024
LFSS 2024: When will the medical devices new measures be applicable?
In its decision no. 2023-860 DC of December 21, 2023, the Constitutional Council ruled on the conformity with the Constitution of…
- Published on 08/01/2024
LFSS 2024: When will the pharmaceutical products new measures be applicable?
In its decision no. 2023-860 DC of December 21, 2023, the Constitutional Council ruled on the conformity with the Constitution of…
- Published on 08/01/2024
LFSS 2024: new paybacks to penalise medical devices with a negative environmental impact
On December 4, 2023, the French National Assembly definitively adopted the Social Security Financing Bill (PLFSS) on final reading without voting. Article…
- Published on 12/12/2023
PLFSS 2024: a new reimbursement regime post early access
Early access makes it possible to finance treatments that are presumed to be innovative and often expensive. However, once this…
- Published on 27/10/2023
Contradictory procedure: what’s at stake in terms of market access?
Many decisions concerning the reimbursement of healthcare products must be preceded by a contradictory procedure. The aim of this procedure…
- Published on 13/10/2023